Skip to main content
SpringerLink
Log in

Pertussis vaccination cost effective in pregnant women

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 2014 US dollars

References

  1. Kim SY, et al. Cost-effectiveness of maternal pertussis immunization: Implications of a dynamic transmission model for low- and middle-income countries. Vaccine 39: 147-157, No. 1, 3 Jan 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.09.012

  2. Luz PM, et al. Modeling the cost-effectiveness of maternal acellular pertussis immunization (aP) in different socioeconomic settings: A dynamic transmission model of pertussis in three Brazilian states. Vaccine 39: 125-136, No. 1, 3 Jan 2021. Available from: URL: http://doi.org/10.1016/j.vaccine.2020.09.008

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pertussis vaccination cost effective in pregnant women. PharmacoEcon Outcomes News 869, 25 (2021). https://doi.org/10.1007/s40274-021-7392-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-021-7392-x

Search

Navigation